Amcor 10-Q 2022-03-31
Filed 2022-05-04. 8 sections, 193K characters. Original on sec.gov · Markdown · JSON
Cover and table of contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended March 31, 2022
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________ to __________
Commission File Number 001-38932
AMCOR PLC
(Exact name of Registrant as specified in its charter)
| Jersey | 98-1455367 | |||||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
83 Tower Road North
Warmley, Bristol BS30 8XP
United Kingdom
(Address of principal executive offices)
Registrant’s telephone number, including area code: +44 117 9753200
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading symbol(s) | Name of each exchange on which registered | ||||||||||||
| Ordinary Shares, Par Value $0.01 Per Share | AMCR | New York Stock Exchange | ||||||||||||
| 1.125% Guaranteed Senior Notes Due 2027 | AUKF/27 | New York Stock Exchange |
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):
| Large Accelerated Filer | ☒ | Emerging Growth Company | ☐ | ||||||||
| Non-Accelerated Filer | ☐ | Smaller Reporting Company | ☐ | ||||||||
| Accelerated Filer | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of May 2, 2022, the registrant had 1,502,766,703 ordinary shares, $0.01 par value, outstanding.
Amcor plc
Quarterly Report on Form 10-Q
Table of Contents
Cautionary Statement Regarding Forward-Looking Statements
Unless otherwise indicated, references to "Amcor," the "Company," "we," "our," and "us" in this Quarterly Report on Form 10-Q refer to Amcor plc and its consolidated subsidiaries.
This Quarterly Report on Form 10-Q contains certain statements that are "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally identified with words like "believe," "expect," "target," "project," "may," "could," "would," "approximately," "possible," "will," "should," "intend," "plan," "anticipate," "estimate," "potential," "outlook," or "continue," the negative of these words, other terms of similar meaning, or the use of future dates. Such statements are based on the current expectations of the management of Amcor and are qualified by the inherent risks and uncertainties surrounding future expectations generally. Actual results could differ materially from those currently anticipated due to a number of risks and uncertainties. None of Amcor or any of its respective directors, executive officers, or advisors, provide any representation, assurance, or guarantee that the occurrence of the events expressed or implied in any forward-looking statements will actually occur. Risks and uncertainties that could cause actual results to differ from expectations include, but are not limited to:
-
changes in consumer demand patterns and customer requirements in numerous industries;
-
the loss of key customers, a reduction in their production requirements, or consolidation among key customers;
-
significant competition in the industries and regions in which we operate;
-
the inability to expand our current business effectively through either organic growth, including by product innovation, or acquisitions;
-
the failure to successfully integrate acquisitions in the expected time frame;
-
challenges to or the loss of our intellectual property rights;
-
adverse impacts from the ongoing 2019 Novel Coronavirus ("COVID-19") pandemic or other similar outbreaks on Amcor and its customers, suppliers, employees, and the geographic markets in which Amcor and its customers operate;
-
challenging current and future global economic conditions;
-
impact of operating internationally, including negative impacts from the Russian invasion of Ukraine;
-
price fluctuations or shortages in the availability of raw materials, energy, and other inputs, which could adversely affect our business;
-
production, supply, and other commercial risks, including counterparty credit risks, which may be exacerbated in times of economic downturn;
-
a failure or disruption in our information technology systems;
-
an inability to attract and retain key personnel;
-
costs and liabilities related to current and future environmental and health and safety laws and regulations;
-
labor disputes;
-
the possibility that the phase out of the London Interbank Offered Rate ("LIBOR") causes our interest expense to increase;
-
foreign exchange rate risk;
-
an increase in interest rates;
-
a significant increase in our indebtedness or a downgrade in our credit rating that could increase our borrowing costs and negatively affect our financial condition and results of operations;
-
a failure to hedge effectively against adverse fluctuations in interest rates and foreign exchange rates;
-
a significant write-down of goodwill and/or other intangible assets;
-
our need to maintain an effective system of internal control over financial reporting;
-
an inability of our insurance policies, including our use of a captive insurance company, to provide adequate protection against all of the risks we face;
-
litigation, including product liability claims, or regulatory developments;
-
increasing scrutiny and changing expectations with respect to our Environmental, Social, and Governance ("ESG") policies resulting in additional costs or exposure to additional risks;
-
changing government regulations in environmental, health, and safety matters;
-
changes in tax laws or changes in our geographic mix of earnings; and
-
our ability to develop and successfully introduce new products and to develop, acquire, and retain intellectual property rights.
These risks and uncertainties are supplemented by those identified from time to time in our filings with the Securities and Exchange Commission, including without limitation, those described under Part I, "Item 1A - Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended June 30, 2021, as updated by our quarterly reports on Form 10-Q. You can obtain copies of Amcor’s filings with the SEC for free at the SEC’s website (www.sec.gov). Forward-looking statements
included herein are made only as of the date hereof and Amcor does not undertake any obligation to update any forward-looking statements, or any other information in this communication, as a result of new information, future developments or otherwise, or to correct any inaccuracies or omissions in them which become apparent, except as expressly required by law. All forward-looking statements in this communication are qualified in their entirety by this cautionary statement.
Part I - Financial Information
Item 1. Financial Statements (unaudited)
Amcor plc and Subsidiaries
Condensed Consolidated Statements of Income
(Unaudited)
| Three Months Ended March 31, | Nine Months Ended March 31, | |||||||||||||||||||||||||
| ($ in millions, except per share data) | 2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||||
| Net sales | $ | 3,708 | $ | 3,207 | $ | 10,635 | $ | 9,407 | ||||||||||||||||||
| Cost of sales | (2,977) | (2,525) | (8,609) | (7,420) | ||||||||||||||||||||||
| Gross profit | 731 | 682 | 2,026 | 1,987 | ||||||||||||||||||||||
| Operating expenses: | ||||||||||||||||||||||||||
| Selling, general, and administrative expenses | (326) | (325) | (942) | (962) | ||||||||||||||||||||||
| Research and development expenses | (24) | (25) | (72) | (74) | ||||||||||||||||||||||
| Restructuring and related expenses, net | (9) | 24 | (27) | (22) | ||||||||||||||||||||||
| Other income/(expense), net | (3) | 17 | 2 | 27 | ||||||||||||||||||||||
| Operating income | 369 | 373 | 987 | 956 | ||||||||||||||||||||||
| Interest income | 5 | 3 | 15 | 10 | ||||||||||||||||||||||
| Interest expense | (36) | (36) | (115) | (113) | ||||||||||||||||||||||
| Other non-operating income, net | 5 | 1 | 12 | 7 | ||||||||||||||||||||||
| Income before income taxes and equity in income of affiliated companies | 343 | 341 | 899 | 860 | ||||||||||||||||||||||
| Income tax expense | (72) | (71) | (196) | (187) | ||||||||||||||||||||||
| Equity in income of affiliated companies, net of tax | — | — | — | 19 | ||||||||||||||||||||||
| Net income | $ | 271 | $ | 270 | $ | 703 | $ | 692 | ||||||||||||||||||
| Net income attributable to non-controlling interests | (2) | (3) | (7) | (8) | ||||||||||||||||||||||
| Net income attributable to Amcor plc | $ | 269 | $ | 267 | $ | 696 | $ | 684 | ||||||||||||||||||
| Basic earnings per share: | $ | 0.178 | $ | 0.173 | $ | 0.457 | $ | 0.439 | ||||||||||||||||||
| Diluted earnings per share: | $ | 0.178 | $ | 0.173 | $ | 0.456 | $ | 0.438 | ||||||||||||||||||
Note: Per share amounts may not add due to rounding. See accompanying notes to condensed consolidated financial statements.
Amcor plc and Subsidiaries
Condensed Consolidated Statements of Comprehensive Income
(Unaudited)
| Three Months Ended March 31, | Nine Months Ended March 31, | |||||||||||||||||||||||||
| ($ in millions) | 2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||||
| Net income | $ | 271 | $ | 270 | $ | 703 | $ | 692 | ||||||||||||||||||
| Other comprehensive income/(loss): | ||||||||||||||||||||||||||
| Net gains/(losses) on cash flow hedges, net of tax (a) | 4 | 7 | (3) | 19 | ||||||||||||||||||||||
| Foreign currency translation adjustments, net of tax (b) | 76 | (25) | (40) | 127 | ||||||||||||||||||||||
| Pension, net of tax (c) | — | 2 | 3 | 4 | ||||||||||||||||||||||
| Other comprehensive income/(loss) | 80 | (16) | (40) | 150 | ||||||||||||||||||||||
| Total comprehensive income | 351 | 254 | 663 | 842 | ||||||||||||||||||||||
| Comprehensive income attributable to non-controlling interests | (4) | (2) | (8) | (8) | ||||||||||||||||||||||
| Comprehensive income attributable to Amcor plc | $ | 347 | $ | 252 | $ | 655 | $ | 834 | ||||||||||||||||||
| (a) Tax benefit/(expense) related to cash flow hedges | $ | — | $ | (2) | $ | 1 | $ | (4) | ||||||||||||||||||
| (b) Tax benefit related to foreign currency translation adjustments | $ | 2 | $ | — | $ | — | $ | 8 | ||||||||||||||||||
| (c) Tax benefit related to pension adjustments | $ | — | $ | — | $ | — | $ | — |
See accompanying notes to condensed consolidated financial statements.
Amcor plc and Subsidiaries
Condensed Consolidated Balance Sheets
(Unaudited)
| ($ in millions, except share and per share data) | March 31, 2022 | June 30, 2021 | ||||||||||||
| Assets | ||||||||||||||
| Current assets: | ||||||||||||||
| Cash and cash equivalents | $ | 1,077 | $ | 850 | ||||||||||
| Trade receivabl |
Showing the first 8K of 104K characters. Open the full section
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Management’s Discussion and Analysis ("MD&A") should be read in conjunction with the Financial Statements and Notes to Condensed Consolidated Financial Statements. Throughout the MD&A, amounts and percentages may not recalculate due to rounding.
Summary of Financial Results
| Three Months Ended March 31, | Nine Months Ended March 31, | |||||||||||||||||||||||||||||||||||||||||||||||||
| ($ in millions) | 2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||||||||||||||||||||||||||||
| Net sales | $ | 3,708 | 100.0 | % | $ | 3,207 | 100.0 | % | $ | 10,635 | 100.0 | % | $ | 9,407 | 100.0 | % | ||||||||||||||||||||||||||||||||||
| Cost of sales | (2,977) | (80.3 | %) | (2,525) | (78.7 | %) | (8,609) | (80.9 | %) | (7,420) | (78.9 | %) | ||||||||||||||||||||||||||||||||||||||
| Gross profit | 731 | 19.7 | % | 682 | 21.3 | % | 2,026 | 19.1 | % | 1,987 | 21.1 | % | ||||||||||||||||||||||||||||||||||||||
| Operating expenses: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Selling, general, and administrative expenses | (326) | (8.8 | %) | (325) | (10.1 | %) | (942) | (8.9 | %) | (962) | (10.2 | %) | ||||||||||||||||||||||||||||||||||||||
| Research and development expenses | (24) | (0.6 | %) | (25) | (0.8 | %) | (72) | (0.7 | %) | (74) | (0.8 | %) | ||||||||||||||||||||||||||||||||||||||
| Restructuring and related expenses, net | (9) | (0.2 | %) | 24 | 0.7 | % | (27) | (0.3 | %) | (22) | (0.2 | %) | ||||||||||||||||||||||||||||||||||||||
| Other income/(expense), net | (3) | (0.1 | %) | 17 | 0.5 | % | 2 | — | % | 27 | 0.3 | % | ||||||||||||||||||||||||||||||||||||||
| Operating income | 369 | 10.0 | % | 373 | 11.6 | % | 987 | 9.3 | % | 956 | 10.2 | % | ||||||||||||||||||||||||||||||||||||||
| Interest income | 5 | 0.1 | % | 3 | 0.1 | % | 15 | 0.1 | % | 10 | 0.1 | % | ||||||||||||||||||||||||||||||||||||||
| Interest expense | (36) | (1.0 | %) | (36) | (1.1 | %) | (115) | (1.1 | %) | (113) | (1.2 | %) | ||||||||||||||||||||||||||||||||||||||
| Other non-operating income, net | 5 | 0.1 | % | 1 | — | % | 12 | 0.1 | % | 7 | 0.1 | % | ||||||||||||||||||||||||||||||||||||||
| Income before income taxes and equity in income of affiliated companies | 343 | 9.3 | % | 341 | 10.6 | % | 899 | 8.5 | % | 860 | 9.1 | % | ||||||||||||||||||||||||||||||||||||||
| Income tax expense | (72) | (1.9 | %) | (71) | (2.2 | %) | (196) | (1.8 | %) | (187) | (2.0 | %) | ||||||||||||||||||||||||||||||||||||||
| Equity in income of affiliated companies, net of tax | — | — | % | — | — | % | — | — | % | 19 | 0.2 | % | ||||||||||||||||||||||||||||||||||||||
| Net income | $ | 271 | 7.3 | % | $ | 270 | 8.4 | % | $ | 703 | 6.6 | % | $ | 692 | 7.4 | % | ||||||||||||||||||||||||||||||||||
| Net income attributable to non-controlling interests | (2) | (0.1 | %) | (3) | (0.1 | %) | (7) | (0.1 | %) | (8) | (0.1 | %) | ||||||||||||||||||||||||||||||||||||||
| Net income attributable to Amcor plc | $ | 269 | 7.3 | % | $ | 267 | 8.3 | % | $ | 696 | 6.5 | % | $ | 684 | 7.3 | % |
Overview
Amcor is a global leader in developing and producing responsible packaging for food, beverage, pharmaceutical, medical, home and personal-care, and other products. We work with leading companies around the world to protect their products and the people who rely on them, differentiate brands, and improve supply chains through a range of flexible and rigid packaging, specialty cartons, closures, and services. We are focused on making packaging that is increasingly light-weighted, recyclable and reusable, and made using an increasing amount of recycled content. During fiscal year 2021, Amcor generated $12.9 billion in sales from operations.
Significant Items Affecting the Periods Presented
Impact of COVID-19
We continue to monitor the impact of the ongoing 2019 Novel Coronavirus ("COVID-19") pandemic on all aspects of our business. The COVID-19 pandemic has resulted in intermittent regional government restrictions on the movement of people, goods, and non-essential services resulting in a period of historic uncertainty and challenges. We remain focused on our commitment to the health and safety of our employees as our first priority. We expect to continue to evaluate our response and related precautions until the COVID-19 pandemic has been resolved as a public health crisis.
We have experienced minimal disruptions to our operations to date as we have largely been d
Showing the first 8K of 61K characters. Open the full section
Item 3. Quantitative and Qualitative Disclosures About Market Risk
There have been no material changes in our market risk during the three and nine months ended March 31, 2022. For additional information, refer to Note 6, "Fair Value Measurements," and Note 7, "Derivative Instruments," to the notes to our unaudited condensed consolidated financial statements, and to "Item 7A. - Quantitative and Qualitative Disclosures About Market Risk" of our Annual Report on Form 10-K for the year ended June 30, 2021.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures as of March 31, 2022. The term "disclosure controls and procedures," as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized, and reported, within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to our management, including its principal executive and financial officers, as appropriate, to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on this evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of March 31, 2022.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the third quarter of fiscal 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Part II - Other Information
Item 1. Legal Proceedings
The material set forth in Note 14, "Contingencies and Legal Proceedings," in "Item 1. Financial Statements - Notes to Condensed Consolidated Financial Statements" is incorporated herein by reference.
Item 1A. Risk Factors
Other than the update to the risk factor set forth below, there have been no material changes from the risk factors contained in "Item 1A. - Risk Factors" of our Annual Report on Form 10-K for the fiscal year ended June 30, 2021. Additional risks not currently known to us or that we currently deem to be immaterial may also materially affect our consolidated financial position, results of operations, or cash flows.
International Operations — Our international operations subject us to various risks that could adversely affect our business operations and financial results.
We have operations throughout the world, including facilities located in emerging markets. In fiscal year 2021, approximately 74% of our sales revenue came from developed markets and 26% came from emerging markets. We expect to continue to expand our operations in the future, particularly in emerging markets.
Management of global operations is extremely complex, particularly given the often substantial differences in the cultural, political, and regulatory environments of the countries in which we operate. In addition, many of the countries in which we operate, including Argentina, Brazil, China, Colombia, India, Peru, Russia, South Africa, and Ukraine, and other emerging markets, have underdeveloped or developing legal, regulatory, or political systems, which are subject to dynamic change and civil unrest.
The profitability of our operations may be adversely impacted by, among other things:
-
changes in applicable fiscal or regulatory regimes;
-
changes in, or difficulties in interpreting and complying with, local laws and regulations, including tax, labor, foreign investment and foreign exchange control laws;
-
nullification, modification or renegotiation of, or difficulties or delays in enforcing, contracts with clients or joint venture partners that are subject to local law;
-
reversal of current political, judicial or administrative policies encouraging foreign investment or foreign trade, or relating to the use of local agents, representatives or partners in the relevant jurisdictions;
-
pandemics, such as COVID-19, impacting various regions of the world unequally; or
-
changes in exchange rates and inflation, including hyperinflation, which may be further exacerbated by the COVID-19 pandemic.
Further, sustained periods of legal, regulatory or political instability in the emerging markets in which we operate could have an adverse effect on our business, cash flow, financial condition, and results of operations, which effect may be material.
For example, the recent conflict between Russia and Ukraine has negatively impacted the global economy and led to various economic sanctions being imposed by the U.S., United Kingdom, European Union, and other countries against Russia. In advance of the conflict, we proactively suspended operations at our small manufacturing site in Ukraine. We also operate three manufacturing facilities in Russia. The four sites in Ukraine and Russia combined represent approximately 2-3% of our consolidated net sales, 4-5% of our annual adjusted EBIT, and approximately $200 million to $300 million of balance sheet exposure. As we announced on March 21, 2022, we are scaling down our activities in Russia by focusing our manufacturing on supporting only existing multinational customers, suspending new projects and investments, and discontinuing exports from Russia as soon as possible. While the impacts of the conflict have not been material on our operating results to date, it is not possible to predict the broader or longer-term consequences of this conflict. Further sanctions as well as steps taken by our customers, suppliers, or other stakeholders may disrupt our ability to continue to operate in Russia or resume operations in Ukraine. Continued escalation of geopolitical tensions related to the conflict could also result in the loss of property, supply chain disruptions, significant inflationary pressure on raw material prices and cost and supply of other resources (such as energy and natural gas), fluctuations in our customers’ buying patterns given regional shortages of food ingredients and other factors, credit and capital market disruption which could impact our ability to obtain financing, increase in interest rates, and adverse foreign exchange impacts. Additional sanctions continue to be enacted and are making ongoing operations in the region increasingly complex and significantly more difficult. These broader consequences could have a material adverse effect on our business, cash flow, financial condition, and results of operations. In addition, the effects of the ongoing conflict could intensify many of our other known risks described in Part I, Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the year ended June 30, 2021, filed with the SEC on August 24, 2021.
The international scope of our operations, which includes limited sales of our products to entities located in countries subject to certain economic sanctions administered by the U.S. Office of Foreign Assets Control, and the U.S. Department of State, and Trade and other applicable national and supranational organizations (collectively, "Sanctions"), and operations in certain countries that are from time to time subject to Sanctions, including those enacted as a result of the Russian invasion of Ukraine, also requires us to maintain internal processes and control procedures. Failure to do so could result in breach by our employees of various laws and regulations, including those relating to money laundering, corruption, export control, fraud, bribery, insider trading, antitrust, competition, and economic sanctions, whether due to a lack of integrity or awareness or otherwise. Any such breach could have an adverse effect on our financial condition and result in reputational damage to our business, which effect may be material.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Share Repurchases
Share repurchase activity during the three months ended March 31, 2022 was as follows (in millions, except number of shares, which are reflected in thousands, and per share amounts, which are expressed in U.S. dollars):
| Period | Total Number of Shares Purchased (1) | Average Price Paid Per Share (1)(2) | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Approximate Dollar Value of Shares That May Yet Be Purchased Under the Programs (3) | ||||||||||||||||||||||
| January 1 - 31, 2022 | — | $ | — | — | $ | 106 | ||||||||||||||||||||
| February 1 - 28, 2022 | 10,961 | 11.68 | 10,961 | 178 | ||||||||||||||||||||||
| March 1 - 31, 2022 | — | — | — | 178 | ||||||||||||||||||||||
| Total | 10,961 | $ | 11.68 | 10,961 |
(1) Includes shares purchased on the open market to satisfy the vesting and exercises of share-based compensation awards.
(2) Average price paid per share excludes costs associated with the repurchase.
(3) On August 17, 2021, our Board of Directors approved a buyback of $400 million of ordinary shares and/or CHESS Depositary Instruments ("CDIs") during the following twelve months. In addition, on February 1, 2022, our Board of Directors approved an additional $200 million buyback of ordinary shares and CDIs during the next twelve months. The timing, volume, and nature of share repurchases may be amended, suspended, or discontinued at any time.
Item 3. Defaults Upon Senior Securities
Not applicable.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
Not applicable.
Item 6. Exhibits
The documents in the accompanying Exhibits Index are filed, furnished, or incorporated by reference as part of this Quarterly Report on Form 10-Q, and such Exhibits Index is incorporated herein by reference.
| Exhibit | Description | ||||||||||||||||
| 22 | Subsidiary Guarantors and Issuers of Guaranteed Securities. | ||||||||||||||||
| 31 | .1 | Chief Executive Officer Certification required by Rules 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as amended. | |||||||||||||||
| 31 | .2 | Chief Financial Officer Certification required by Rules 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as amended. | |||||||||||||||
| 32 | Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of Sarbanes Oxley Act of 2002. | ||||||||||||||||
| 101 | .INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data file because its XBRL tags are embedded within the Inline XBRL document. | |||||||||||||||
| 101 | .SCH | Inline XBRL Taxonomy Extension Schema Document. | |||||||||||||||
| 101 | .CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | |||||||||||||||
| 101 | .DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. | |||||||||||||||
| 101 | .LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. | |||||||||||||||
| 101 | .PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | |||||||||||||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| AMCOR PLC | |||||||||||
| Date | May 4, 2022 | By | /s/ Michael Casamento | ||||||||
| Michael Casamento, Executive Vice President and Chief Financial Officer (Principal Financial Officer) | |||||||||||
| Date | May 4, 2022 | By | /s/ Julie Sorrells | ||||||||
| Julie Sorrells, Vice President and Corporate Controller (Principal Accounting Officer) |